Metabolomics yield a novel biomarker for predicting diabetes mellitus risk in humans

Circulation: Cardiovascular Genetics

Volumn 7, Issue 1, 2014, Pages 95-96

  Arora, Pankaj ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Biomarkers; Diabetes mellitus; Metabolomics

Indexed keywords

2 AMINOADIPIC ACID; BIOLOGICAL MARKER; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

CARDIOMETABOLIC RISK; DIABETES MELLITUS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIPID DIET; LIQUID CHROMATOGRAPHY; METABOLOMICS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; PROGENY; SHORT SURVEY; TANDEM MASS SPECTROMETRY;

BIOMARKERS; DIABETES MELLITUS; METABOLOMICS;

2-AMINOADIPIC ACID; ANIMALS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE;

EID: 84898725796     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.114.000528     Document Type: Short Survey

References (3)

1. Gerszten RE, Wang TJ. The search for new cardiovascular biomarkers. Nature. 2008;451:949-952.
2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
3. Wang TJ, Ngo D, Psychogios N, Dejam A, Larson MG, Vasan RS, et al. 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest. 2013;123:4309-4317.